Image

Single-cell and Spatial Transcriptomic Profiling of Gingival Tissues in Aggressive and Chronic Periodontitis: Deciphering Cellular Heterogeneity and Inflammatory Microenvironment Features

Single-cell and Spatial Transcriptomic Profiling of Gingival Tissues in Aggressive and Chronic Periodontitis: Deciphering Cellular Heterogeneity and Inflammatory Microenvironment Features

Recruiting
20-40 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to investigate cellular heterogeneity and inflammatory microenvironment features in gingival tissues from patients with aggressive periodontitis compared to chronic periodontitis and healthy controls, using single-cell and spatial transcriptomics combined with whole-genome sequencing.

The main question(s) it aims to answer are:

What are the differences in cellular composition, mesenchymal stem cell subpopulations, and gene expression profiles between aggressive periodontitis, chronic periodontitis, and healthy gingival tissues? Which key molecular markers, signaling pathways, and spatially resolved microenvironment patterns distinguish aggressive periodontitis from the more common chronic form? Are there disease-specific genetic variants associated with aggressive periodontitis identified through whole-genome sequencing of peripheral blood DNA?

Participants (already scheduled for tooth extraction or periodontal surgery as part of routine clinical care) will undergo:

Standard clinical periodontal examination and CBCT imaging Collection of a small gingival tissue sample (\~1×3×1 mm) during the planned extraction/surgery under local anesthesia Collection of 5 mL peripheral blood for DNA extraction No additional intervention, treatment, or follow-up visit is required beyond routine dental care.

Last updated: December 23, 2025

Eligibility

Inclusion Criteria:

Aggressive Periodontitis Patients:

  1. Aged 20-35 years
  2. Radiographic evidence of at least 30% vertical bone loss at ≥2 tooth sites
  3. Can be classified as Stage III/IV, Grade C periodontitis according to the 2018 new classification of periodontitis
  4. With or without family history of periodontitis
  5. No significant local contributing factors (e.g., calculus, occlusal trauma, etc.)

Chronic Periodontitis Patients:

  1. Aged 30-40 years
  2. ≥3 sites with probing depth ≥5 mm
  3. Can be classified as Stage I/II, Grade A/B periodontitis according to the 2018 new classification of periodontitis
  4. No significant family history
  5. Disease predominantly driven by local factors (dental plaque, calculus, etc.)

Healthy Controls:

  1. Aged 20-40 years
  2. Radiographic examination shows no significant alveolar bone loss
  3. Clinically cannot be diagnosed with gingivitis or periodontitis

Exclusion Criteria:

  1. Use of antibiotics within the past 3 months
  2. Smoking \>10 cigarettes per day
  3. Uncontrolled severe diabetes (HbA1c level ≥6.7%)
  4. Planning pregnancy, currently pregnant, or breastfeeding
  5. Alcohol or drug addiction
  6. Long-term use of immunosuppressive agents
  7. Infectious diseases such as hepatitis or AIDS/HIV
  8. History of malignant tumor, radiotherapy, or chemotherapy within the past 5 years

Study details
    Periodontis
    Aggressive Periodontitis

NCT07487272

Second Affiliated Hospital, School of Medicine, Zhejiang University

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.